Literature DB >> 21110226

When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it.

Punam A Pabari1, Keith Willson, Berthold Stegemann, Irene E van Geldorp, Andreas Kyriacou, Michela Moraldo, Jamil Mayet, Alun D Hughes, Darrel P Francis.   

Abstract

Impact of variability in the measured parameter is rarely considered in designing clinical protocols for optimization of atrioventricular (AV) or interventricular (VV) delay of cardiac resynchronization therapy (CRT). In this article, we approach this question quantitatively using mathematical simulation in which the true optimum is known and examine practical implications using some real measurements. We calculated the performance of any optimization process that selects the pacing setting which maximizes an underlying signal, such as flow or pressure, in the presence of overlying random variability (noise). If signal and noise are of equal size, for a 5-choice optimization (60, 100, 140, 180, 220 ms), replicate AV delay optima are rarely identical but rather scattered with a standard deviation of 45 ms. This scatter was overwhelmingly determined (ρ = -0.975, P < 0.001) by Information Content, [Formula: see text], an expression of signal-to-noise ratio. Averaging multiple replicates improves information content. In real clinical data, at resting, heart rate information content is often only 0.2-0.3; elevated pacing rates can raise information content above 0.5. Low information content (e.g. <0.5) causes gross overestimation of optimization-induced increment in VTI, high false-positive appearance of change in optimum between visits and very wide confidence intervals of individual patient optimum. AV and VV optimization by selecting the setting showing maximum cardiac function can only be accurate if information content is high. Simple steps to reduce noise such as averaging multiple replicates, or to increase signal such as increasing heart rate, can improve information content, and therefore viability, of any optimization process.

Entities:  

Mesh:

Year:  2011        PMID: 21110226      PMCID: PMC3074062          DOI: 10.1007/s10741-010-9203-5

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  16 in total

1.  Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure.

Authors:  Zachary I Whinnett; Justin E R Davies; Keith Willson; Anthony W Chow; Rodney A Foale; D Wyn Davies; Alun D Hughes; Darrel P Francis; Jamil Mayet
Journal:  Europace       Date:  2006-05       Impact factor: 5.214

2.  Measurement precision in the optimization of cardiac resynchronization therapy.

Authors:  Robert G Turcott; Ronald M Witteles; Paul J Wang; Randall H Vagelos; Michael B Fowler; Euan A Ashley
Journal:  Circ Heart Fail       Date:  2010-02-22       Impact factor: 8.790

3.  Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay.

Authors:  Z I Whinnett; J E R Davies; K Willson; C H Manisty; A W Chow; R A Foale; D Wyn Davies; A D Hughes; J Mayet; D P Francis
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

4.  A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy.

Authors:  Michael R Gold; Imran Niazi; Michael Giudici; Robert B Leman; J Lacy Sturdivant; Michael H Kim; Yinghong Yu; Jiang Ding; Alan D Waggoner
Journal:  J Cardiovasc Electrophysiol       Date:  2007-02-21

Review 5.  Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization.

Authors:  S Serge Barold; Arzu Ilercil; Bengt Herweg
Journal:  Europace       Date:  2008-11       Impact factor: 5.214

6.  Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy.

Authors:  Maria Cristina Porciani; Cristina Dondina; Roberto Macioce; Gabriele Demarchi; Francesco Cappelli; Alessio Lilli; Alessia Pappone; Giuseppe Ricciardi; Paolo C Colombo; Margherita Padeletti; Sanja Jelic; Luigi Padeletti
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

7.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay.

Authors:  D A Kass; C H Chen; C Curry; M Talbot; R Berger; B Fetics; E Nevo
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

8.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group.

Authors:  A Auricchio; C Stellbrink; M Block; S Sack; J Vogt; P Bakker; H Klein; A Kramer; J Ding; R Salo; B Tockman; T Pochet; J Spinelli
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

9.  Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study.

Authors:  R A Nishimura; D L Hayes; D R Holmes; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

10.  The role of repeating optimization of atrioventricular interval during interim and long-term follow-up after cardiac resynchronization therapy.

Authors:  Qing Zhang; Jeffrey Wing-Hong Fung; Yat-Sun Chan; Hamish Chi-Kin Chan; Hong Lin; Skiva Chan; Cheuk-Man Yu
Journal:  Int J Cardiol       Date:  2007-04-17       Impact factor: 4.164

View more
  15 in total

1.  Cardiac resynchronization therapy update: evolving indications, expanding benefit?

Authors:  C Butcher; Y Mareev; V Markides; M Mason; T Wong; J G F Cleland
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 2.  Strategies to improve cardiac resynchronization therapy.

Authors:  Kevin Vernooy; Caroline J M van Deursen; Marc Strik; Frits W Prinzen
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

3.  The acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.

Authors:  Charlotte H Manisty; Ali Al-Hussaini; Beth Unsworth; Resham Baruah; Punam A Pabari; Jamil Mayet; Alun D Hughes; Zachary I Whinnett; Darrel P Francis
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-11-17

Review 4.  The "missing" link between acute hemodynamic effect and clinical response.

Authors:  Frits W Prinzen; Angelo Auricchio
Journal:  J Cardiovasc Transl Res       Date:  2011-11-17       Impact factor: 4.132

5.  A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy.

Authors:  Andreas Kyriacou; Matthew E Li Kam Wa; Punam A Pabari; Beth Unsworth; Resham Baruah; Keith Willson; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Zachary I Whinnett; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

6.  Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally.

Authors:  Andreas Kyriacou; Punam A Pabari; Jamil Mayet; Nicholas S Peters; D Wyn Davies; P Boon Lim; David Lefroy; Alun D Hughes; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  Int J Cardiol       Date:  2013-10-16       Impact factor: 4.164

7.  Vectorcardiography for optimization of stimulation intervals in cardiac resynchronization therapy.

Authors:  Caroline J M van Deursen; Liliane Wecke; Wouter M van Everdingen; Marcus Ståhlberg; Michel H G Janssen; Frieder Braunschweig; Lennart Bergfeldt; Harry J G M Crijns; Kevin Vernooy; Frits W Prinzen
Journal:  J Cardiovasc Transl Res       Date:  2015-03-06       Impact factor: 4.132

8.  Echocardiography and cardiac resynchronisation therapy, friends or foes?

Authors:  W M van Everdingen; J C Schipper; J van 't Sant; K Ramdat Misier; M Meine; M J Cramer
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

9.  British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Siana Jones; Andreas Kyriacou; Katherine March; Emma Coady; Jamil Mayet; Alun D Hughes; Michael Frenneaux; Darrel P Francis
Journal:  BMC Cardiovasc Disord       Date:  2014-04-03       Impact factor: 2.298

10.  Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice.

Authors:  Zachary I Whinnett; Darrel P Francis; Arnaud Denis; Keith Willson; Patrizio Pascale; Irene van Geldorp; Maxime De Guillebon; Sylvain Ploux; Kenneth Ellenbogen; Michel Haïssaguerre; Philippe Ritter; Pierre Bordachar
Journal:  Int J Cardiol       Date:  2013-03-05       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.